Trial Profile
A double blind, randomized placebo controlled study of the efficacy, safety and tolerability of quetiapine fumarate sustained release (Seroquel SRTM) in the treatment of major depression with comorbid fibromyalgia syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2014
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Fibromyalgia; Major depressive disorder
- Focus Therapeutic Use
- 01 Feb 2014 Results published in the Arthritis and Rheumatology.
- 09 Oct 2013 Primary endpoint 'Hamilton-Depression-Rating-Scale' has been met.
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.